We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

CEPHEID

Develops, manufactures, and markets molecular systems and tests for institutions to perform sophisticated genetic tes... read more Featured Products: More products

Download Mobile App




Five Methods Evaluated for Constrictive Tuberculous Pericarditis Diagnosis

By LabMedica International staff writers
Posted on 24 May 2022

Constrictive pericarditis is a rare and serious disease that accounts for approximately 0. More...

5%–2% of all heart diseases. It results in decreased pericardial compliance and can severely affect the diastolic filling function of the heart, mainly as a symptom of right heart failure, such as multiple plasma chamber effusions and edema.

Constrictive pericarditis has a poor prognosis, and pericardiectomy is the primary treatment of choice. It has several etiologies, including infection (e.g., tuberculosis [MTB], viral infection, and bacterial infection), malignancy, or radiation therapy. MTB is the most common etiology of constrictive pericarditis in developing countries.

Clinical Diagnosticians at the Zhejiang University School of Medicine (Hangzhou, China) reviewed the case histories of patients with suspected constrictive tuberculous pericarditis (TBP) hospitalized between June 1, 2019 and June 31, 2021, who underwent five tests using pericardial tissue. Fresh, diseased pericardial tissue collected during pericardial dissection was used to perform the five tests. A total of 69 patients were included.

Ground pericardial tissue specimens were centrifuged at 3000 g for approximately 15 minutes. The treated deposits were examined by smear microscopy using Auramine O fluorescent dye and stained with Ziehl–Neelsen for confirmation (AFB). Lowenstein–Jensen solid medium and liquid culture medium BACTEC MGIT 960 Mycobacteria Culture System (BD Diagnostic Systems, Sparks, MD, USA) were used for MTB culture.

The CapitalBio Mycobacterium RT-PCR detection kit (CapitalBio Technology Inc., Beijing, China) provided simultaneous screening of MTB and nontuberculous mycobacteria (NTM) infections. It employs duplex fluorescence RT-PCR and TaqMan probe technology to detect both MTB and NTM infections in one test. The Xpert MTB/RIF assay (Cepheid, Sunnyvale, CA, USA) was also included for comparision. Histological sections were subjected to pathological examination and anti-acid staining by an experienced pathology professional.

The investigators reported that the sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and AUC of AFB smear were 7.3%, 100.0%, 100.0%, 21.5%, and 0.54, respectively. Those of culture were 23.6%, 100.0%, 100.0%, 25.0%, and 0.62, respectively. Those of Xpert MTB/RIF were 52.7%, 100.0%, 100.0%, 35.0%, and 0.76, respectively. Those of CapitalBio assay were 50.9%, 100.0%, 100.0%, 34.2%, and 0.75, respectively. Those of pathology were 92.7%, 92.9%, 98.1%, 76.5%, and 0.93, respectively.

The authors concluded that the diagnosis of constrictive TBP remains challenging. The validity of AFB smear and MTB culture using pericardial tissues remains low. NAATs can provide diagnostic efficacy for TBP, but the efficacy is moderate. The CapitalBio assay and Xpert MTB/RIF could be considered similar for diagnosing TBP. The role of pathology in the diagnosis of constrictive TBP cannot be ignored, considering that pathology showed the best diagnostic accuracy among the five tests. The diagnostic accuracy of the same test is similar in acute or subacute TBP and chronic TBP. The study was published on April 13, 2022 in the International Journal of Infectious Diseases.

Related Links:
Zhejiang University School of Medicine 
BD Diagnostic Systems
CapitalBio Technology Inc
Cepheid


New
Gold Member
Latex Test
SLE-Latex Test
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Automatic Hematology Analyzer
LABAS F9000
New
Staining Management Software
DakoLink
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.